JMP Securities Initiates Coverage On Agilon Health with Market Outperform Rating, Announces Price Target of $18
Portfolio Pulse from Benzinga Newsdesk
JMP Securities analyst Constantine Davides has initiated coverage on Agilon Health (NYSE:AGL) with a Market Outperform rating and set a price target of $18.
December 06, 2023 | 10:40 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Agilon Health received a Market Outperform rating from JMP Securities with a price target of $18, indicating a positive outlook from the analyst.
Analyst ratings can significantly influence investor sentiment and stock prices. The initiation of coverage with a Market Outperform rating suggests that JMP Securities sees strong potential in Agilon Health, and the announcement of an $18 price target could lead to increased investor interest and a potential short-term rise in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100